172@29@16@56!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=1&is_responsive=1&sec=&priceinter=1&frommc=1!~!|commonstore|commonfiles|moneycontrol_header.php
Moneycontrol
SENSEX NIFTY
you are here:

Novartis India Ltd.

BSE: 500672 | NSE: NOVARTIND | Series: NA | ISIN: INE234A01025 | SECTOR: Pharmaceuticals

BSE Live

Aug 10, 16:00
637.75 -1.10 (-0.17%)
Volume
AVERAGE VOLUME
5-Day
31,909
10-Day
29,245
30-Day
20,147
17,716
  • Prev. Close

    638.85

  • Open Price

    651.95

636.50

Today’s L/H

651.95
420.05

52 Wk L/H

780.00
511.10

L/U Price Band

766.60
  • Bid Price (Qty.)

    637.75 (33)

  • Offer Price (Qty.)

    637.75 (45)

  •  VWAP

    640.91
     Beta
    0.36
  • Market Depth (10 Aug 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    25 638.00 639.50 25
    38 637.30 639.60 10
    4 637.20 639.65 40
    10 636.60 639.90 1
    10 636.55 642.85 10
    1802 Total Total 3937
     Market Depth
    BUY 1802.00
    SELL 3937.00
    31%
    69%

NSE Live

Dec 27, 11:22
217.15 -1.70 (-0.78%)
Volume
No Data Available
6,787,243
  • Prev. Close

    218.85

  • Open Price

    -

216.10

Today’s L/H

220.70

52 Wk L/H

L/U Price Band

  • Bid Price (Qty.)

    - (0)

  • Offer Price (Qty.)

    - (0)

  •  VWAP

    -
     Beta
    0.43
  • DELIVERY AVERAGES
    3-Day
    0%
    5-Day
    0%
    8-Day
    0%
    Deliverables
    0%
  • SMA
    30
    50
    150
    200
    SMA
Novartis India is not listed on NSE

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Very Bearish
Moving Averages Bearish
Technical Indicators Bearish
Moving Averages Crossovers Bearish
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 219.87 222.58 224.47 217.98 215.27 213.38 210.67
Fibonacci 219.74 220.83 222.58 217.98 216.23 215.14 213.38
Camarilla 217.57 217.99 218.42 217.98 216.73 216.31 215.88

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 219.22
10 221.86
20 222.27
50 229.40
100 244.18
200 238.87
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels

Type R1 R2 R3 PP S1 S2 S3
Classic 225.10 233.05 237.55 220.60 212.65 208.15 200.20
Fibonacci 225.36 228.29 233.05 220.60 215.84 212.91 208.15
Camarilla 218.29 219.43 220.57 220.60 216.01 214.87 213.73

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 230.73 244.32 252.08 222.97 209.38 201.62 188.03
Fibonacci 231.12 236.16 244.32 222.97 214.81 209.77 201.62
Camarilla 219.11 221.06 223.02 222.97 215.19 213.24 211.28

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      1,574.66
    • P/E
      115.12
    • Book Value (Rs)
      291.90
    • Dividend (%)
      200.00
    • Market Lot
      1
    • Industry P/E
      37.18
    • EPS (TTM)
      5.54
    • P/C
      58.72
    • Price/Book
      2.18
    • Dividend Yield.(%)
      1.57
    • Face Value (RS)
      5.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      61.89
      5-Day
      62.48
      8-Day
      62.99
      59.89

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      1,574.66
    • P/E
      -
    • Book Value (Rs)
      -
    • Dividend (%)
      200.00
    • Market Lot
      1
    • Industry P/E
      37.18
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      -
    • Dividend Yield.(%)
      1.57
    • Face Value (RS)
      -
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      61.89
      5-Day
      62.48
      8-Day
      62.99
      59.89

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

  • 100% BUY
  • 0% SELL
  • 0% HOLD
100%
of moneycontrol users recommend buying Novartis India

What's your call on Novartis India today?

Read 4 investor views

BUY SELL HOLD

Action in Novartis India Ltd.

Pre-Opening Session Prices9:00 am - 9:15 am

BSE

Aug 11, 09:15
651.95 13.10 (2.05%)
High 664.00
Low 651.95
Prev. Close 638.85
NSE - No shares traded

Financials

(Rs. Cr)
Quarterly JUN 2020 MAR 2020 DEC 2019 SEP 2019 JUN 2019
Sales
92.46 93.70 117.46 117.78 109.31
Other Income
6.96 7.94 7.30 10.01 10.89
Total Income
99.42 101.64 124.76 127.79 120.20
Total Expenditure
91.33 86.20 111.72 123.71 117.73
EBIT
8.09 15.44 13.04 4.08 2.47
Interest
1.68 1.89 1.66 1.68 1.16
Tax
2.02 6.77 3.65 7.62 0.52
Net Profit
4.39 6.78 7.73 -5.22 0.79

Historical Prices

On
Current Price %Gain / Loss
Open Price 607.25 651.95
7.36
High Price 607.25 651.95
7.36
Low Price 581.25 636.50
9.51
Close Price 583.90 638.85
9.41
Volume 18,749 17,716
-5.51
On
Current Price %Gain / Loss
No Record Found
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 11270.20 56.20 0.50
SENSEX 38182.08 141.51 0.37
NIFTY BANK 21900.25 146.25 0.67
NIFTY IT 18159.55 155.35 0.86
S&P BSE Smallcap 13869.08 200.39 1.47
Index Price Change %Chg
Nikkei 225 (Aug 11) 22,691.43 361.49 1.62
KOSPI (Aug 11) 2,418.46 32.08 1.34
Straits Times (Aug 11) 2,548.09 2.58 0.10
Taiwan Weighted (Aug 11) 12,854.84 -39.16 -0.30
SGX Nifty (Aug 11) 11,359.00 40.00 0.35

CORPORATE ACTION

Date Agenda
Aug 06, 2020 Quarterly Results
Jun 19, 2020 Audited Results & Final Dividend
Feb 11, 2020 Quarterly Results
Nov 08, 2019 Quarterly Results
Type Dividend% Ex-Dividend date
Final 200.00 Jul 29, 2020
Final 200.00 Jul 31, 2019
Final 200.00 Jul 18, 2018
Final 200.00 Jul 19, 2017
Final 200.00 Jul 21, 2016
Ratio Announcement Date Ex-Bonus
1:2 Jan 16, 1990 Dec 10, 1990
Old FV New FV Ex-Split
10 5 Nov 06, 2000
Ratio Premium Ex-Bonus
No Rights Information is available for Novartis India
Date Agenda
Aug 07, 2020 -
Aug 09, 2019 -
Mar 22, 2019 -
Jul 27, 2018 -
Nov 22, 2017 -

Dividend Summary

For the year ending March 2020 Novartis India has declared an equity dividend of 200.00% amounting to Rs 10 per share. At the current share price of Rs 217.15 this results in a dividend yield of 4.61%.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone March 2020 June 2019 March 2019 December 2018
Promoters 70.68 70.68 70.68 70.68
Pledged 0 0 0 0
FII/FPI 0.04 0.12 0.16 0.21
Total DII 6.32 6.39 6.23 6.14
Fin.Insts 0.02 0.93 0.93 0.93
Insurance Co 0.8 0 0 0
MF 0 0 0 0
Others DIIs 5.5 5.46 5.3 5.21
Others 22.96 22.8 22.92 22.96
Total 100 99.99 99.99 99.99

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Novartis India 637.75 -0.17 780.00 420.05 1574.66 438.25 10.08
Sun Pharma 543.75 3.41 550.70 315.20 130463.84 12,531.93 3,211.14
Divis Labs 3117.10 11.95 3228.05 1466.95 82749.21 5,310.57 1,372.71
Dr Reddys Labs 4692.55 2.65 4754.30 2352.00 78005.44 11,850.40 2,937.70
Cipla 795.65 9.20 814.45 356.75 64153.9 12,659.15 2,318.17

COMPANY OVERVIEW

Novartis India Limited is a pharmaceutical company. The business operations of the Company include Pharmaceuticals, Generic, over the counter (OTC) and Animal Health. The Pharmaceuticals segment consists of a portfolio of prescription medicines, which are provided to patients through healthcare professionals. The Generics segment consists of retail generics products. The Generics segments unit primarily focuses on the therapeutic segments, such as Anti-TB, Anti-DUB (Gynaecology), Anti-histamines, Antibiotics, Anti-ulcerants, Anti-diabetes and Cardiovascular. The Animal Health segment has a presence primarily in the cattle and poultry market segments. The OT C segment is mainly in the vitamins, minerals and nutritional supplements (VMS) and cough, cold and allergy (CoCoA) market segments. During the fiscal year ended March 31, 2012, it introduced Enplus product in the Poultry segment, and Dexbov, Antifur, Vayuhara, Vetimam and Feedavit in the Cattle segment..The company also in the business activities of OTC, Generics, Animal Health, Pharmaceuticals.

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • Christopher Snook

      Chairman

    • Sanjay Murdeshwar

      Vice Chairman & Mng.Director

    • Monaz Noble

      WholeTime Director & CFO

    • Jai Hiremath

      Director

    • Rajendra Nath Mehrotra

      Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Novartis India Ltd.

Novartis India is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 500672 and the NSE with an NSE Code of NOVARTIND.

Related Searches